Why tirzepatide ordering is a protocol-economics problem on AnazaoHealth
AnazaoHealth is a direct 503A compounder — not a marketplace. Tirzepatide programs run across a wide titration range, and the landed cost per vial can change as the patient escalates. That makes the ordering question economic: to price a protocol you need per-vial 503A cost at each step, not a single blended rate from a clinic agreement. Prescribers submit patient-specific orders through the myAnazao portal; Anazao compounds and ships from its Tampa 503A facility. Tirzepatide availability, concentrations, and vial sizes are confirmed through your sales representative — they are not published on anazaohealth.com.
This page covers ordering workflow and economics, not clinical dosing. The titration schedule is a prescriber decision; the platform's job is to make the right vial reach the patient with a correct SIG and to show what each step costs. What you should evaluate is whether the platform surfaces per-step per-vial cost and validation so the protocol orders cleanly and predictably.